| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |